Precise Compression, Uncompromised Flow – The New Standard in Post-Transradial Hemostasis

The transradial approach (TRA) has become the preferred route for coronary interventional diagnosis and treatment. Compared with the transfemoral approach, TRA offers significant advantages, including fewer bleeding complications, greater patient comfort, and the ability to ambulate shortly after the procedure. Currently, transradial interventions account for over 90% of coronary procedures in China, making it the mainstream choice in this field.

However, post-procedural hemostasis at the radial puncture site—specifically, how to achieve rapid hemostasis while preventing radial artery occlusion (RAO)—remains a central clinical concern. Precise compression with uncompromised flow is exactly what the next-generation radial artery compression devices aim to achieve.

What Is “Precise Compression”?

The central dilemma in radial hemostasis is:

● Insufficient pressure → Failed hemostasis at the puncture site, leading to hematoma or pseudoaneurysm

● Excessive pressure → Complete occlusion of radial artery flow, significantly increasing the risk of RAO

Traditional elastic compression devices rely heavily on operator experience, making pressure quantification difficult. In contrast, modern balloon-type and screw-type compression devices enable precise, controllable pressure:

Balloon-type: Syringe precisely controls balloon volume, thereby quantifying compression pressure

Screw/knob-type: Rotating screw incrementally advances the compression pad; color-coded indicator shows safe pressure range

“Precise compression” means achieving hemostasis with the lowest effective pressure, a concept that directly reduces the risk of RAO.

What Is “Uncompromised Flow”?

International guidelines strongly recommend the use of non-occlusive hemostasis. The core principle is to achieve hemostasis while maintaining antegrade flow in the radial artery.

Why is “uncompromised flow” so important?

● When the radial artery is completely occluded (flow interrupted), the incidence of RAO increases significantly

● Some post‑procedural RAO is asymptomatic but may compromise future ipsilateral transradial procedures

● A patent radial artery can serve as a conduit for coronary artery bypass grafting (CABG) or be used to create an arteriovenous fistula for dialysis

“Uncompromised flow” carries two meanings:

①Immediate patency: The radial artery maintains antegrade flow throughout hemostasis

② Long-term patency: RAO is avoided, preserving the radial artery for future Vascular Access

How Does the Next-Generation Compression Device Become “the New Standard”?

Traditional hemostasis methods are being replaced by more scientific and safer designs. The next-generation radial artery compression device offers the following key features:

1. Visualized and Quantifiable Pressure Adjustment

● Balloon-type devices include a graduated syringe; the inflation volume corresponds to a clear pressure range

● Screw-type devices feature a color-coded indicator window (e.g., green zone = safe pressure, red zone = excessive pressure)

● Studies show that pressure visualization significantly reduces the incidence of RAO

2. Enhanced Patient Comfort and Tolerance

● Soft materials: The balloon and straps are made of medical‑grade soft materials to minimize local compression pain

● Venous return‑friendly design: Gaps on both sides of the device prevent complete venous occlusion, reducing hand swelling, numbness, and pain

● Suitable for extended wear (6‑12 hours post‑procedure), improving patient compliance

3. Easy Operation and Time Savings

● Velcro strap: Enables rapid wrist fixation and can be operated with one hand

● Transparent window: Allows direct observation of the puncture site for bleeding without device removal

● Fine‑adjustment mechanism (screw‑type devices): Allows precise pressure reduction without loosening the strap, simplifying post‑procedural care

4. Broad Clinical Compatibility

● Compatible with different sheath sizes (5Fr–7Fr) used after radial puncture

● Some models also accommodate ulnar artery compression, meeting the needs of different access sites

Clinical Value: From Data to Practice

Clinical studies have demonstrated that adopting precise compression with non‑occlusive hemostasis leads to:

● Significant reduction in RAO incidence: from 5‑10% with traditional compression to <2%

● Hemostasis success rate: >95%

● Patient satisfaction: significantly higher than that achieved with elastic bands

For the catheterization laboratory, the next‑generation compression device means:

● Fewer post‑procedural bleeding complications

● Shorter enforced bed rest time after the procedure

● Improved patient throughput

Disclaimer: This article is for medical popularization, purposes only and does not constitute professional medical advice. Please always follow the diagnosis and treatment plans provided by your treating physician.